カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の破傷風ワクチン市場予測2023-2029：ジフテリア・破傷風（DT）ワクチン、ジフテリア・破傷風・百日咳（百日咳）（DTaP）ワクチン、破傷風・ジフテリア（Td）ワクチン、破傷風・ジフテリア・百日咳（Tdap）ワクチン

【英語タイトル】Tetanus Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8705）・商品コード：MMG23LY8705
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：78
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の破傷風ワクチン市場規模と予測を収録しています。・世界の破傷風ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の破傷風ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の破傷風ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ジフテリア・破傷風（DT）ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

破傷風ワクチンのグローバル主要企業は、GlaxoSmithKline plc、 Pfizer,Inc、 Merck & Co.,Inc、 Sanofi Pasteur SA、 Biological E、 Dano Vaccine &Biological Pvt.Ltd.,、 Panera、 Shantha Biotechnics Ltdなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、破傷風ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の破傷風ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の破傷風ワクチン市場：タイプ別市場シェア、2022年
・ジフテリア・破傷風（DT）ワクチン、ジフテリア・破傷風・百日咳（百日咳）（DTaP）ワクチン、破傷風・ジフテリア（Td）ワクチン、破傷風・ジフテリア・百日咳（Tdap）ワクチン

世界の破傷風ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の破傷風ワクチン市場：用途別市場シェア、2022年
・成人、小児

世界の破傷風ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の破傷風ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における破傷風ワクチンのグローバル売上、2018年-2023年
・主要企業における破傷風ワクチンのグローバル売上シェア、2022年
・主要企業における破傷風ワクチンのグローバル販売量、2018年-2023年
・主要企業における破傷風ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GlaxoSmithKline plc、 Pfizer,Inc、 Merck & Co.,Inc、 Sanofi Pasteur SA、 Biological E、 Dano Vaccine &Biological Pvt.Ltd.,、 Panera、 Shantha Biotechnics Ltd

*************************************************************

・調査・分析レポートの概要
破傷風ワクチン市場の定義
市場セグメント
世界の破傷風ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の破傷風ワクチン市場規模
世界の破傷風ワクチン市場規模：2022年 VS 2029年
世界の破傷風ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの破傷風ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の破傷風ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ジフテリア・破傷風（DT）ワクチン、ジフテリア・破傷風・百日咳（百日咳）（DTaP）ワクチン、破傷風・ジフテリア（Td）ワクチン、破傷風・ジフテリア・百日咳（Tdap）ワクチン
破傷風ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：成人、小児
破傷風ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別破傷風ワクチン市場規模 2022年と2029年
地域別破傷風ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline plc、 Pfizer,Inc、 Merck & Co.,Inc、 Sanofi Pasteur SA、 Biological E、 Dano Vaccine &Biological Pvt.Ltd.,、 Panera、 Shantha Biotechnics Ltd
...

Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.

The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.

A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.

The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.
This report aims to provide a comprehensive presentation of the global market for Tetanus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tetanus Vaccine. This report contains market size and forecasts of Tetanus Vaccine in global, including the following market information:
Global Tetanus Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Tetanus Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Tetanus Vaccine companies in 2022 (%)
The global Tetanus Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Diphtheria and tetanus (DT) vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tetanus Vaccine include GlaxoSmithKline plc, Pfizer,Inc, Merck & Co.,Inc, Sanofi Pasteur SA, Biological E, Dano Vaccine &Biological Pvt.Ltd.,, Panera and Shantha Biotechnics Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tetanus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tetanus Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Tetanus Vaccine Market Segment Percentages, by Type, 2022 (%)
Diphtheria and tetanus (DT) vaccines
Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
Tetanus and diphtheria (Td) vaccines
Tetanus, diphtheria, and pertussis (Tdap) vaccines
Global Tetanus Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Tetanus Vaccine Market Segment Percentages, by Application, 2022 (%)
Adult
Pediatric
Global Tetanus Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Tetanus Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tetanus Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Tetanus Vaccine revenues share in global market, 2022 (%)
Key companies Tetanus Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Tetanus Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline plc
Pfizer,Inc
Merck & Co.,Inc
Sanofi Pasteur SA
Biological E
Dano Vaccine &Biological Pvt.Ltd.,
Panera
Shantha Biotechnics Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tetanus Vaccine, market overview.
Chapter 2: Global Tetanus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Tetanus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tetanus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Tetanus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Tetanus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tetanus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tetanus Vaccine Overall Market Size
2.1 Global Tetanus Vaccine Market Size: 2022 VS 2029
2.2 Global Tetanus Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Tetanus Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Tetanus Vaccine Players in Global Market
3.2 Top Global Tetanus Vaccine Companies Ranked by Revenue
3.3 Global Tetanus Vaccine Revenue by Companies
3.4 Global Tetanus Vaccine Sales by Companies
3.5 Global Tetanus Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Tetanus Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Tetanus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tetanus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Tetanus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Tetanus Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Tetanus Vaccine Market Size Markets, 2022 & 2029
4.1.2 Diphtheria and tetanus (DT) vaccines
4.1.3 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
4.1.4 Tetanus and diphtheria (Td) vaccines
4.1.5 Tetanus, diphtheria, and pertussis (Tdap) vaccines
4.2 By Type – Global Tetanus Vaccine Revenue & Forecasts
4.2.1 By Type – Global Tetanus Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Tetanus Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Tetanus Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Tetanus Vaccine Sales & Forecasts
4.3.1 By Type – Global Tetanus Vaccine Sales, 2018-2023
4.3.2 By Type – Global Tetanus Vaccine Sales, 2024-2029
4.3.3 By Type – Global Tetanus Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Tetanus Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Tetanus Vaccine Market Size, 2022 & 2029
5.1.2 Adult
5.1.3 Pediatric
5.2 By Application – Global Tetanus Vaccine Revenue & Forecasts
5.2.1 By Application – Global Tetanus Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Tetanus Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Tetanus Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Tetanus Vaccine Sales & Forecasts
5.3.1 By Application – Global Tetanus Vaccine Sales, 2018-2023
5.3.2 By Application – Global Tetanus Vaccine Sales, 2024-2029
5.3.3 By Application – Global Tetanus Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Tetanus Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Tetanus Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Tetanus Vaccine Revenue & Forecasts
6.2.1 By Region – Global Tetanus Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Tetanus Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Tetanus Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Tetanus Vaccine Sales & Forecasts
6.3.1 By Region – Global Tetanus Vaccine Sales, 2018-2023
6.3.2 By Region – Global Tetanus Vaccine Sales, 2024-2029
6.3.3 By Region – Global Tetanus Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Tetanus Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Tetanus Vaccine Sales, 2018-2029
6.4.3 US Tetanus Vaccine Market Size, 2018-2029
6.4.4 Canada Tetanus Vaccine Market Size, 2018-2029
6.4.5 Mexico Tetanus Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Tetanus Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Tetanus Vaccine Sales, 2018-2029
6.5.3 Germany Tetanus Vaccine Market Size, 2018-2029
6.5.4 France Tetanus Vaccine Market Size, 2018-2029
6.5.5 U.K. Tetanus Vaccine Market Size, 2018-2029
6.5.6 Italy Tetanus Vaccine Market Size, 2018-2029
6.5.7 Russia Tetanus Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Tetanus Vaccine Market Size, 2018-2029
6.5.9 Benelux Tetanus Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Tetanus Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Tetanus Vaccine Sales, 2018-2029
6.6.3 China Tetanus Vaccine Market Size, 2018-2029
6.6.4 Japan Tetanus Vaccine Market Size, 2018-2029
6.6.5 South Korea Tetanus Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Tetanus Vaccine Market Size, 2018-2029
6.6.7 India Tetanus Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Tetanus Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Tetanus Vaccine Sales, 2018-2029
6.7.3 Brazil Tetanus Vaccine Market Size, 2018-2029
6.7.4 Argentina Tetanus Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Tetanus Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Tetanus Vaccine Sales, 2018-2029
6.8.3 Turkey Tetanus Vaccine Market Size, 2018-2029
6.8.4 Israel Tetanus Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Tetanus Vaccine Market Size, 2018-2029
6.8.6 UAE Tetanus Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Company Summary
7.1.2 GlaxoSmithKline plc Business Overview
7.1.3 GlaxoSmithKline plc Tetanus Vaccine Major Product Offerings
7.1.4 GlaxoSmithKline plc Tetanus Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline plc Key News & Latest Developments
7.2 Pfizer,Inc
7.2.1 Pfizer,Inc Company Summary
7.2.2 Pfizer,Inc Business Overview
7.2.3 Pfizer,Inc Tetanus Vaccine Major Product Offerings
7.2.4 Pfizer,Inc Tetanus Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer,Inc Key News & Latest Developments
7.3 Merck & Co.,Inc
7.3.1 Merck & Co.,Inc Company Summary
7.3.2 Merck & Co.,Inc Business Overview
7.3.3 Merck & Co.,Inc Tetanus Vaccine Major Product Offerings
7.3.4 Merck & Co.,Inc Tetanus Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Merck & Co.,Inc Key News & Latest Developments
7.4 Sanofi Pasteur SA
7.4.1 Sanofi Pasteur SA Company Summary
7.4.2 Sanofi Pasteur SA Business Overview
7.4.3 Sanofi Pasteur SA Tetanus Vaccine Major Product Offerings
7.4.4 Sanofi Pasteur SA Tetanus Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Pasteur SA Key News & Latest Developments
7.5 Biological E
7.5.1 Biological E Company Summary
7.5.2 Biological E Business Overview
7.5.3 Biological E Tetanus Vaccine Major Product Offerings
7.5.4 Biological E Tetanus Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Biological E Key News & Latest Developments
7.6 Dano Vaccine &Biological Pvt.Ltd.,
7.6.1 Dano Vaccine &Biological Pvt.Ltd., Company Summary
7.6.2 Dano Vaccine &Biological Pvt.Ltd., Business Overview
7.6.3 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Major Product Offerings
7.6.4 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Dano Vaccine &Biological Pvt.Ltd., Key News & Latest Developments
7.7 Panera
7.7.1 Panera Company Summary
7.7.2 Panera Business Overview
7.7.3 Panera Tetanus Vaccine Major Product Offerings
7.7.4 Panera Tetanus Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Panera Key News & Latest Developments
7.8 Shantha Biotechnics Ltd
7.8.1 Shantha Biotechnics Ltd Company Summary
7.8.2 Shantha Biotechnics Ltd Business Overview
7.8.3 Shantha Biotechnics Ltd Tetanus Vaccine Major Product Offerings
7.8.4 Shantha Biotechnics Ltd Tetanus Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Shantha Biotechnics Ltd Key News & Latest Developments
8 Global Tetanus Vaccine Production Capacity, Analysis
8.1 Global Tetanus Vaccine Production Capacity, 2018-2029
8.2 Tetanus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Tetanus Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tetanus Vaccine Supply Chain Analysis
10.1 Tetanus Vaccine Industry Value Chain
10.2 Tetanus Vaccine Upstream Market
10.3 Tetanus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tetanus Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Tetanus Vaccine in Global Market
Table 2. Top Tetanus Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Tetanus Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Tetanus Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Tetanus Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Tetanus Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Tetanus Vaccine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Tetanus Vaccine Product Type
Table 9. List of Global Tier 1 Tetanus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tetanus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Tetanus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Tetanus Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Tetanus Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Tetanus Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Tetanus Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Tetanus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Tetanus Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Tetanus Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Tetanus Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Tetanus Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Tetanus Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Tetanus Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Tetanus Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Tetanus Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Tetanus Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Tetanus Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Tetanus Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Tetanus Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Tetanus Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Tetanus Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Tetanus Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Tetanus Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Tetanus Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Tetanus Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Tetanus Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Tetanus Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Tetanus Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Tetanus Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Tetanus Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Tetanus Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Tetanus Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Tetanus Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Tetanus Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Tetanus Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Tetanus Vaccine Sales, (K Units), 2024-2029
Table 46. GlaxoSmithKline plc Company Summary
Table 47. GlaxoSmithKline plc Tetanus Vaccine Product Offerings
Table 48. GlaxoSmithKline plc Tetanus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. GlaxoSmithKline plc Key News & Latest Developments
Table 50. Pfizer,Inc Company Summary
Table 51. Pfizer,Inc Tetanus Vaccine Product Offerings
Table 52. Pfizer,Inc Tetanus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer,Inc Key News & Latest Developments
Table 54. Merck & Co.,Inc Company Summary
Table 55. Merck & Co.,Inc Tetanus Vaccine Product Offerings
Table 56. Merck & Co.,Inc Tetanus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Merck & Co.,Inc Key News & Latest Developments
Table 58. Sanofi Pasteur SA Company Summary
Table 59. Sanofi Pasteur SA Tetanus Vaccine Product Offerings
Table 60. Sanofi Pasteur SA Tetanus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Sanofi Pasteur SA Key News & Latest Developments
Table 62. Biological E Company Summary
Table 63. Biological E Tetanus Vaccine Product Offerings
Table 64. Biological E Tetanus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Biological E Key News & Latest Developments
Table 66. Dano Vaccine &Biological Pvt.Ltd., Company Summary
Table 67. Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Product Offerings
Table 68. Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Dano Vaccine &Biological Pvt.Ltd., Key News & Latest Developments
Table 70. Panera Company Summary
Table 71. Panera Tetanus Vaccine Product Offerings
Table 72. Panera Tetanus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Panera Key News & Latest Developments
Table 74. Shantha Biotechnics Ltd Company Summary
Table 75. Shantha Biotechnics Ltd Tetanus Vaccine Product Offerings
Table 76. Shantha Biotechnics Ltd Tetanus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Shantha Biotechnics Ltd Key News & Latest Developments
Table 78. Tetanus Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Tetanus Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Tetanus Vaccine Production by Region, 2018-2023 (K Units)
Table 81. Global Tetanus Vaccine Production by Region, 2024-2029 (K Units)
Table 82. Tetanus Vaccine Market Opportunities & Trends in Global Market
Table 83. Tetanus Vaccine Market Drivers in Global Market
Table 84. Tetanus Vaccine Market Restraints in Global Market
Table 85. Tetanus Vaccine Raw Materials
Table 86. Tetanus Vaccine Raw Materials Suppliers in Global Market
Table 87. Typical Tetanus Vaccine Downstream
Table 88. Tetanus Vaccine Downstream Clients in Global Market
Table 89. Tetanus Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Tetanus Vaccine Segment by Type in 2022
Figure 2. Tetanus Vaccine Segment by Application in 2022
Figure 3. Global Tetanus Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tetanus Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Tetanus Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Tetanus Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Tetanus Vaccine Revenue in 2022
Figure 9. By Type - Global Tetanus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Tetanus Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Tetanus Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Tetanus Vaccine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Tetanus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Tetanus Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Tetanus Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Tetanus Vaccine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Tetanus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Tetanus Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Tetanus Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Tetanus Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Tetanus Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Tetanus Vaccine Sales Market Share, 2018-2029
Figure 23. US Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Tetanus Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Tetanus Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Tetanus Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Tetanus Vaccine Sales Market Share, 2018-2029
Figure 37. China Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Tetanus Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Tetanus Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Tetanus Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Tetanus Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Tetanus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Tetanus Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Tetanus Vaccine by Region, 2022 VS 2029
Figure 54. Tetanus Vaccine Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の破傷風ワクチン市場予測2023-2029：ジフテリア・破傷風（DT）ワクチン、ジフテリア・破傷風・百日咳（百日咳）（DTaP）ワクチン、破傷風・ジフテリア（Td）ワクチン、破傷風・ジフテリア・百日咳（Tdap）ワクチン] (コード：MMG23LY8705)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の破傷風ワクチン市場予測2023-2029：ジフテリア・破傷風（DT）ワクチン、ジフテリア・破傷風・百日咳（百日咳）（DTaP）ワクチン、破傷風・ジフテリア（Td）ワクチン、破傷風・ジフテリア・百日咳（Tdap）ワクチン]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のDTaP＆Tdapワクチン市場予測2023-2029：DTaP、Td、Tdap
  • 世界のDPTワクチン接種市場2022年：DTaP、Tdap、DTwP
  • 世界のDTPワクチン市場2022年：百日咳、ジフテリア、破傷風
  • 世界の性感染症治療薬市場2022年：抗ウイルス薬・抗レトロウイルス薬、抗生物質、ワクチン
  • 世界のジフテリア/破傷風/百日咳（DPT）ワクチン市場予測2023-2029：DTwP型、DTaP型

    • ◆H&Iグローバルリサーチのお客様（例）◆